SARS-CoV-2蛋白沉积增强肾补体激活并加重COVID-19后膜性肾病肾损伤
INTRODUCTION: COVID-19 has been reported to be associated with the occurrence and recurrence of membranous nephropathy (MN). The clinicopathological characteristics and complement system activation of MN after COVID-19 are unclear.…
要点
- COVID-19后膜性肾病患者临床表现较疫情前原发性膜性肾病更重。
- 肾组织SARS-CoV-2核衣壳蛋白阳性者肾病综合征比例更高、血清白蛋白更低、肾间质纤维化更重。
- COVID-19后膜性肾病患者血清MAC水平及肾组织MAC染色强度显著高于对照,且SARS-CoV-2阳性者MAC表达更强。
核心结论
- 补体系统过度激活加重了COVID-19后膜性肾病的症状,可能需要考虑针对补体系统的治疗策略。
研究设计与样本
- 对38例COVID-19后膜性肾病患者行肾组织SARS-CoV-2核衣壳蛋白免疫组化染色,用酶联免疫吸附法检测血清MAC,用免疫组化检测不同补体通路蛋白的肾小球染色。
主要发现
- 与对照相比,COVID-19后膜性肾病患者临床表现更严重。
- SARS-CoV-2染色阳性者较阴性者肾病综合征比例更高、血清白蛋白水平更低、肾间质纤维化更严重。
- COVID-19后膜性肾病患者血清MAC水平及肾组织MAC染色强度显著高于对照。
- SARS-CoV-2阳性者MAC表达强于对照及SARS-CoV-2阴性的COVID-19后膜性肾病患者,且因子H表达趋势与MAC一致。
临床怎么用
- 对COVID-19后新发蛋白尿的膜性肾病患者,应关注补体系统过度激活及肾间质纤维化程度。
- 肾组织SARS-CoV-2核衣壳蛋白阳性可能提示更重的临床与病理表型。
- 针对补体系统的治疗策略可能需在COVID-19后膜性肾病中予以考虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: COVID-19 has been reported to be associated with the occurrence and recurrence of membranous nephropathy (MN). The clinicopathological characteristics and complement system activation of MN after COVID-19 are unclear. METHODS: A total of 38 patients with biopsy-proven MN who developed new-onset proteinuria after COVID-19 were enrolled in this study. One hundred patients with primary MN diagnosed before the COVID-19 pandemic were the control. Renal immunohistochemical staining for SARS-CoV-2 nucleocapsid protein was performed in 38 patients with MN after COVID-19. Serum membrane attack complex (MAC) was detected by enzyme-linked immunosorbent assay. Glomerular staining for the complement proteins in different pathways were detected by immunohistochemistry. RESULTS: Thirteen of 38 patients had positive staining for SARS-CoV-2 nucleocapsid protein. Compared with the control patients, the clinical manifestations were more severe in patients after COVID-19. Patients with positive SARS-CoV-2 staining had a higher proportion of nephrotic syndrome, lower level of serum albumin, and greater severity of renal interstitial fibrosis than those of patients with negative SARS-CoV-2 staining. Serum MAC level and renal MAC staining intensity of MN after COVID-19 were significantly higher than those of the control patients. MAC expression in MN patients with positive SARS-CoV-2 staining was stronger than that in both control patients and MN after COVID-19 with negative SARS-CoV-2 staining. The expression trend of factor H was consistent with that of MAC. CONCLUSION: Excessive activation of the complement system aggravated symptoms in MN after COVID-19. Therapeutic strategy targeting the complement system may need to be considered.
引用
- Wang G, Yang L, Xu X, et al. SARS-CoV-2 Protein Deposition Enhances Renal Complement Activation and Aggravates Kidney Injury in Membranous Nephropathy After COVID-19. Kidney Int Rep. 2024. PMID: 39534192. doi:10.1016/j.ekir.2024.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。